• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养教育计划对超重/肥胖非酒精性脂肪性肝病患者的影响:一项单盲平行随机对照试验。

The Effect of Nutrition Education Program on Overweight/Obese Patients with Non-Alcoholic Fatty Liver Disease: a Single-Blind Parallel Randomized Controlled Trial.

作者信息

Arab Arman, Hadi Amir, Moosavian Seyedeh Parisa, Rafie Nahid, Hajianfar Hossein

机构信息

Department of Community Nutrition, School of Nutrition and Food Science, Food Security Research Center, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.

Halal Research Center of IRI, FDA, Tehran 314715311, Iran.

出版信息

Clin Nutr Res. 2019 Jul 29;8(3):238-246. doi: 10.7762/cnr.2019.8.3.238. eCollection 2019 Jul.

DOI:10.7762/cnr.2019.8.3.238
PMID:31384602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6675958/
Abstract

UNLABELLED

The aim of this study was to assess the effects of a nutrition education program on overweight/obese patients with non-alcoholic fatty liver disease (NAFLD). This single-blind, parallel randomized controlled trial was conducted on 82 NAFLD patients (mean age 48.89 ± 9.85 years) in Isfahan, Iran. Patients were randomly allocated to receive nutrition education program combined with usual care or usual care alone for 2 months. Metabolic markers, including lipid profile, fasting blood glucose (FBG) and dietary intakes were obtained for each patient at baseline and at the end of the study. Nutrition education intervention resulted in a significant decrease compared with usual care in serum levels of total cholesterol (TC) and triglyceride (TG) (p < 0.05). However, our intervention did not lead to a significant improvement in FBG, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), respectively (p > 0.05). Furthermore, energy and sugar intakes of patients were reduced significantly in response to our intervention (p < 0.05). Nutrition education intervention significantly reduced serum levels of TC and TG but did not affect other metabolic markers including FBG, LDL-C, and HDL-C. Also, it could reduce total energy and sugar intake. Thus, this study could be useful to use this educational program for NAFLD patients in order to influence their metabolic markers and dietary intakes.

TRIAL REGISTRATION

IRCT Identifier: IRCT2014101811763N17.

摘要

未标注

本研究的目的是评估营养教育计划对超重/肥胖非酒精性脂肪性肝病(NAFLD)患者的影响。这项单盲、平行随机对照试验在伊朗伊斯法罕的82名NAFLD患者(平均年龄48.89±9.85岁)中进行。患者被随机分配接受营养教育计划联合常规护理或仅接受常规护理,为期2个月。在基线和研究结束时,为每位患者获取代谢指标,包括血脂谱、空腹血糖(FBG)和饮食摄入量。与常规护理相比,营养教育干预使血清总胆固醇(TC)和甘油三酯(TG)水平显著降低(p<0.05)。然而,我们的干预分别未导致FBG、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)有显著改善(p>0.05)。此外,患者的能量和糖摄入量因我们的干预而显著减少(p<0.05)。营养教育干预显著降低了血清TC和TG水平,但未影响包括FBG、LDL-C和HDL-C在内的其他代谢指标。此外,它可以减少总能量和糖摄入量。因此,本研究对于将该教育计划用于NAFLD患者以影响其代谢指标和饮食摄入量可能是有用的。

试验注册

IRCT标识符:IRCT2014101811763N17。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed8/6675958/7bd1a8c13977/cnr-8-238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed8/6675958/7bd1a8c13977/cnr-8-238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed8/6675958/7bd1a8c13977/cnr-8-238-g001.jpg

相似文献

1
The Effect of Nutrition Education Program on Overweight/Obese Patients with Non-Alcoholic Fatty Liver Disease: a Single-Blind Parallel Randomized Controlled Trial.营养教育计划对超重/肥胖非酒精性脂肪性肝病患者的影响:一项单盲平行随机对照试验。
Clin Nutr Res. 2019 Jul 29;8(3):238-246. doi: 10.7762/cnr.2019.8.3.238. eCollection 2019 Jul.
2
Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.小豆蔻补充剂可改善超重或肥胖非酒精性脂肪性肝病患者的血清鸢尾素、血糖指数和血脂谱:一项双盲随机安慰剂对照临床试验。
BMC Complement Altern Med. 2019 Mar 12;19(1):59. doi: 10.1186/s12906-019-2465-0.
3
Effect of lifestyle modification education based on health belief model in overweight/obese patients with non-alcoholic fatty liver disease: A parallel randomized controlled clinical trial.基于健康信念模式的生活方式改变教育对超重/肥胖非酒精性脂肪性肝病患者的影响:一项平行随机对照临床试验。
Clin Nutr ESPEN. 2020 Aug;38:236-241. doi: 10.1016/j.clnesp.2020.04.004. Epub 2020 Apr 24.
4
Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.奥利司他在新诊断为非酒精性脂肪性肝病的肥胖患者中的补充作用:对代谢参数、人体测量指数以及 PPAR-α、UCP1 和 UCP2 基因表达的影响。
Pharmacol Res. 2020 Jun;156:104770. doi: 10.1016/j.phrs.2020.104770. Epub 2020 Mar 23.
5
The effects of zinc supplementation on metabolic profile and oxidative stress in overweight/obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.锌补充剂对非酒精性脂肪性肝病超重/肥胖患者代谢特征及氧化应激的影响:一项随机、双盲、安慰剂对照试验。
J Trace Elem Med Biol. 2020 Dec;62:126635. doi: 10.1016/j.jtemb.2020.126635. Epub 2020 Aug 28.
6
The effect of behavioral intervention and nutrition education program on serum lipid profile, body weight and blood pressure in Iranian individuals with spinal cord injury: A randomized clinical trial.行为干预和营养教育计划对伊朗脊髓损伤患者血脂谱、体重和血压的影响:一项随机临床试验。
J Spinal Cord Med. 2018 Jan;41(1):28-35. doi: 10.1080/10790268.2016.1209890. Epub 2016 Aug 25.
7
[Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].[中药化解法对多囊卵巢综合征伴非酒精性脂肪性肝病脂质代谢的影响]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Jun;33(6):751-6.
8
Effects of oleoylethanolamide supplementation on atherogenic indices and hematological parameters in patients with nonalcoholic fatty liver disease: A clinical trial.补充油酰乙醇胺对非酒精性脂肪性肝病患者动脉粥样硬化指数和血液学参数的影响:一项临床试验。
Health Promot Perspect. 2020 Nov 7;10(4):373-382. doi: 10.34172/hpp.2020.56. eCollection 2020.
9
10
A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.一项关于吡啶甲酸铬补充剂对非酒精性脂肪性肝病患者血清胎球蛋白 A、代谢和炎症因子影响的初步研究:一项双盲、安慰剂对照试验。
J Trace Elem Med Biol. 2021 Jan;63:126659. doi: 10.1016/j.jtemb.2020.126659. Epub 2020 Sep 30.

引用本文的文献

1
Circulating lipoprotein(a) in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.非酒精性脂肪性肝病患者循环脂蛋白(a):一项系统评价和荟萃分析。
J Gastroenterol Hepatol. 2024 Dec;39(12):2572-2581. doi: 10.1111/jgh.16768. Epub 2024 Oct 17.
2
Non-alcoholic fatty liver disease: The importance of physical activity and nutrition education-A randomized controlled study.非酒精性脂肪性肝病:体育活动和营养教育的重要性——一项随机对照研究。
J Gastroenterol Hepatol. 2024 Dec;39(12):2723-2734. doi: 10.1111/jgh.16756. Epub 2024 Sep 29.
3
A Scoping Review of Epidemiological Studies on Intake of Sugars in Geographically Dispersed Asian Countries: Comparison of Dietary Assessment Methodology.

本文引用的文献

1
DELTA guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.关于选择目标差异以及进行和报告随机对照试验样本量计算的DELTA指南。
Trials. 2018 Nov 5;19(1):606. doi: 10.1186/s13063-018-2884-0.
2
Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.补充特级初榨橄榄油或坚果的地中海饮食对心血管疾病的一级预防
N Engl J Med. 2018 Jun 21;378(25):e34. doi: 10.1056/NEJMoa1800389. Epub 2018 Jun 13.
3
Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.
地理上分散的亚洲国家糖摄入量的流行病学研究述评:膳食评估方法的比较。
Adv Nutr. 2022 Oct 2;13(5):1947-1973. doi: 10.1093/advances/nmac061.
4
The Effects of Foods on Blood Lipids in Non-alcoholic Fatty Liver Disease (NAFLD)-A Systematic Review and Meta-Analysis.食物对非酒精性脂肪性肝病(NAFLD)患者血脂的影响——一项系统评价和荟萃分析
Front Nutr. 2020 Dec 16;7:613221. doi: 10.3389/fnut.2020.613221. eCollection 2020.
非酒精性脂肪性肝病/非酒精性脂肪性肝炎的全球流行病学:我们未来的需求。
Liver Int. 2018 Feb;38 Suppl 1:47-51. doi: 10.1111/liv.13643.
4
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis.非酒精性脂肪性肝病与 2 型糖尿病发病风险:荟萃分析。
Diabetes Care. 2018 Feb;41(2):372-382. doi: 10.2337/dc17-1902.
5
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.非酒精性脂肪性肝病作为代谢和肝脏疾病的纽带。
Cell Metab. 2018 Jan 9;27(1):22-41. doi: 10.1016/j.cmet.2017.08.002. Epub 2017 Aug 31.
6
The Effect of a Lifestyle Modification Education on Adiposity Measures in Overweight and Obese Nonalcoholic Fatty Liver Disease Patients.生活方式改良教育对超重和肥胖非酒精性脂肪性肝病患者肥胖指标的影响。
Int J Prev Med. 2017 Feb 23;8:10. doi: 10.4103/2008-7802.200854. eCollection 2017.
7
The 2015 Dietary Guidelines Advisory Committee Scientific Report: Development and Major Conclusions.《2015年膳食指南咨询委员会科学报告:制定过程与主要结论》
Adv Nutr. 2016 May 16;7(3):438-44. doi: 10.3945/an.116.012120. Print 2016 May.
8
NAFLD, NASH and liver cancer.非酒精性脂肪性肝病、非酒精性脂肪性肝炎和肝癌。
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):656-65. doi: 10.1038/nrgastro.2013.183. Epub 2013 Oct 1.
9
Prospective associations between sugar-sweetened beverage intakes and cardiometabolic risk factors in adolescents.青少年含糖饮料摄入量与心血管代谢风险因素的前瞻性关联。
Am J Clin Nutr. 2013 Aug;98(2):327-34. doi: 10.3945/ajcn.112.051383. Epub 2013 May 29.
10
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.糖尿病患者心血管疾病的一级预防:美国心脏协会和美国糖尿病协会的科学声明
Circulation. 2007 Jan 2;115(1):114-26. doi: 10.1161/CIRCULATIONAHA.106.179294. Epub 2006 Dec 27.